Herbistry420
hybrid

GG #4 03302022 L1 Test Sample

Caryophyllene-dominant
THC
14.3–19.3%
Dominant Terpene
Caryophyllene

About

GG #4 03302022 L1 Test Sample is a hybrid cannabis strain. Lab samples test between 14.3% and 19.3% THC, with caryophyllene (0.47%) as the dominant terpene.

Why does GG #4 03302022 L1 Test Sample feel pain-relieving?

GG #4 03302022 L1 Test Sample's pain-relieving effects are linked to its dominant caryophyllene (0.47%), one of the few terpenes that binds directly to CB2 cannabinoid receptors. Complemented by myrcene (0.18%), which has sedative and muscle-relaxant properties.

Strain Profile

Energy
CalmingEnergizing
Potency
Low THCHigh THC

May Help With

Inflammation100%

Caryophyllene has strong anti-inflammatory properties

Pain86%

Caryophyllene binds to CB2 receptors for pain relief

Insomnia31%

Myrcene's sedative properties may aid sleep

Stress22%

Limonene is associated with stress relief

Based on terpene research and reported effects. Not medical advice. Consult a healthcare professional for medical decisions.

Quick Info

Type
hybrid
Breeder
Not verified
THC
14.3–19.3%
Chemotype
Caryophyllene-dominant

What is Caryophyllene?

Spicy, peppery terpene found in black pepper, cloves, and cinnamon.

Learn more →

Share

Share
← Back to all strains

About GG #4 03302022 L1 Test Sample

Is GG #4 03302022 L1 Test Sample indica or sativa?
GG #4 03302022 L1 Test Sample is a hybrid cannabis strain. Hybrids combine characteristics of both indica and sativa genetics.
What is the THC content of GG #4 03302022 L1 Test Sample?
GG #4 03302022 L1 Test Sample typically tests at 14.3% to 19.3% THC.
What terpenes are in GG #4 03302022 L1 Test Sample?
The dominant terpenes in GG #4 03302022 L1 Test Sample are Caryophyllene, Myrcene, Humulene. Terpenes influence the aroma, flavor, and effects of a cannabis strain.